EC 2.7.11.13 - ATP:protein phosphotransferase (diacylglycerol- dependent) (protein kinase C)
3D structures of EC 2.7.11.13 - protein kinase C in Protein Data Bank
updated: 6 January 2022, 2:15
In total: 50 PDB structures of EC 2.7.11.13 - protein kinase C:
- 3iw4: Crystal Structure of Pkc Alpha in Complex with Nvp-aeb071
- 3gpe: Crystal Structure Analysis of Pkc (alpha)-c2 Domain Complexed with Ca2+ and Ptdins(4,5)p2
- 3a8x: Crystal Structure of Pkciota Kinase Domain
- 3a8w: Crystal Structure of Pkciota Kinase Domain
- 2yuu: Solution Structure of The First Phorbol Esters/diacylglycerol Binding Domain of Human Protein Kinase C, Delta
- 2wh0: Recognition of an Intrachain Tandem 14-3-3 Binding Site within Protein Kinase C Epsilon
- 2uzp: Crystal Structure of The C2 Domain of Human Protein Kinase C Gamma.
- 2rmk: Rac1/prk1 Complex
- 2e73: Solution Structure of The Phorbol Esters/diacylglycerol Binding Domain of Protein Kinase C Gamma
- 2eli: Solution Structure of The Second Phorbol Esters/diacylglycerol Binding Domain of Human Protein Kinase C Alpha Type
- 2enj: Solution Sturcture of The C2 Domain from Human Protein Kinase C Theta
- 2enn: Solution Structure of The First C1 Domain from Human Protein Kinase C Theta
- 2enz: Solution Structure of The Second C1 Domain from Human Protein Kinase C Theta
- 2i0e: Structure of Catalytic Domain of Human Protein Kinase C Beta II Complexed with a Bisindolylmaleimide Inhibitor
- 2jed: The Crystal Structure of The Kinase Domain of The Protein Kinase C Theta in Complex with Nvp-xaa228 at 2.32a Resolution.
- 6uwa: Mouse Pkc C1B and C2 Domains
- 3pfq: Crystal Structure and Allosteric Activation of Protein Kinase C Beta II
- 3rdj: Rat Pkc C2 Domain Apo
- 3twy: Rat Pkc C2 Domain Bound to Pb
- 6ra0: A Ubiquitin-like Dimerization Domain Controls Protein Kinase D Activation by Trans-autophosphorylation
- 3txo: Pkc Eta Kinase in Complex with a Naphthyridine
- 4dnl: Crystal Structure of a C2 Domain of a Protein Kinase C Alpha (prkca) from Homo Sapiens at 1.90 a Resolution
- 4dc2: Structure of Pkc in Complex with a Substrate Peptide from Par-3
- 6ilz: Crystal Structure of Pkciota in Complex with Inhibitor
- 3uej: Structural and Functional Characterization of an Anesthetic Binding Site in The Second Cysteine-rich Domain of Protein Kinase Cdelta
- 3uey: Structural and Functional Characterization of an Anesthetic Binding Site in The Second Cysteine-rich Domain of Protein Kinase Cdelta
- 3uff: Structural and Functional Characterization of an Anesthetic Binding Site in The Second Cysteine-rich Domain of Protein Kinase Cdelta
- 3ugd: Structural and Functional Characterization of an Anesthetic Binding Site in The Second Cysteine-rich Domain of Protein Kinase C Delta
- 3ugi: Structural and Functional Characterization of an Anesthetic Binding Site in The Second Cysteine-rich Domain of Protein Kinase C Delta
- 3ugl: Structural and Functional Characterization of an Anesthetic Binding Site in The Second Cysteine-rich Domain of Protein Kinase C Delta
- 3zh8: A Novel Small Molecule Apkc Inhibitor
- 4fkd: Identification of The Activator Binding Residues in The Second Cysteine-rich Regulatory Domain of Protein Kinase C Theta
- 6gbe: Murine Protein Tyrosine Phosphatase Ptpn13 Pdz3 Domain-prk2 Peptide Complex
- 4crs: Human Protein Kinase N2 (pkn2, Prkcl2) in Complex with Atpgammas
- 4l1l: Rat Pkc C2 Domain Bound to Cd
- 4mjs: Crystal Structure of a Pb1 Complex
- 4nkg: Crystal Structure of Ssph1 Lrr Domain in Complex Pkn1 HR1B Domain
- 4otd: Crystal Structure of Prk1 Catalytic Domain
- 4otg: Crystal Structure of Prk1 Catalytic Domain in Complex with Lestaurtinib
- 4oth: Crystal Structure of Prk1 Catalytic Domain in Complex with Ro-31-8220
- 4oti: Crystal Structure of Prk1 Catalytic Domain in Complex with Tofacitinib
- 4q9z: Human Protein Kinase C Theta in Complex with Compound35 ((1r)-9- (azetidin-3-ylamino)-1,8-dimethyl-3,5-dihydro[1,2,4]triazino[3,4- C][1,4]benzoxazin-2(1h)-one)
- 5w4s: Solution Structure of C2 Domain from Protein Kinase C Alpha in Ternary Complex with Calcium and V5-phm Peptide
- 4ra4: Crystal Structure of Human Protein Kinase C Alpha in Complex with Compound 28 ((r)-6-((3s,4s)-1,3-dimethyl-piperidin-4-yl)-7-(2-fluoro- Phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)
- 4ra5: Human Protein Kinase C Theta in Complex with Ligand Compound 11a (6- [(1,3-dimethyl-azetidin-3-yl)-methyl-amino]-4(r)-methyl-7-phenyl-2, 10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)
- 5lih: Structure of a Peptide-substrate Bound to Pkciota Core Kinase Domain
- 5li9: Structure of a Nucleotide-bound Form of Pkciota Core Kinase Domain
- 5li1: Structure of a Par3-inhibitory Peptide Bound to Pkciota Core Kinase Domain
- 5f9e: Structure of Protein Kinase C Theta with Compound 10: 2,2-dimethyl-7- (2-oxidanylidene-3~{h}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)- 3~{h}-quinazolin-4-one
- 2nce: Solution Structure of Ca2+-bound C2 Domain from Protein Kinase C Alpha in The Form of Complex with V5-phm Peptide
|